Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes

Blood

Volumn 90, Issue 10, 1997, Pages 4162-4171

  Dickensheets, Harold L ^b   Freeman, Sherry L ^b   Smith Jr , Michael F ^b   Donnelly, Raymond P ^a  

^a HFM 505   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MACROPHAGE FUNCTION; MONOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

EID: 0030781492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4162     Document Type: Article

References (63)

1. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53:45, 1988
2. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K: Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555, 1994
3. Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A: Effect of γ-interferon on cachectin expression by mononuclear phagocytes. J Exp Med 164:1791, 1986
4. Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB: Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 140:3473, 1988
5. Hayes MP, Freeman SL, Donnelly RP: Interferon-γ priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability. Cytokine 7:427, 1995
6. 2. Proc Natl Acad Sci USA 86:3803, 1989
7. Donnelly RP. Fenton MJ, Finbloom DS, Gerrard TL: Differential regulation of IL-1 production in human monocytes by IFN-γ and IL-4. J Immunol 145:569, 1990
8. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
9. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 151:6370, 1993
10. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151, 1992
11. Imamura K, Spriggs D, Kufe D: Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J Immunol 139:2989, 1987
12. Philippe C, Roux-Lombard P, Fouqueray B, Perez J, Dayer J-M, Baud L: Membrane expression and shedding of tumor necrosis factor receptors during activation of human blood monocytes: Regulation by desferrioxamine. Immunology 80:300, 1993
13. Leeuwenberg JFM, Dentener MA, Buurman WA: Lipopoly-saccharide-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J Immunol 152:5070, 1994
14. van der Poll T, Calvano SE, Kumar A, Braxton CC, Coyle SM, Barbosa K, Moldawer LL, Lowry SF: Endotoxin induces down-regulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood 86:2754, 1995
15. Ding AH, Sanchez E, Srimal S, Nathan CF: Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 264:3924, 1989
16. Higuchi M, Aggarwal BB: TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550, 1994
17. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331, 1990
18. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 89:4845, 1992
19. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323, 1992
20. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548, 1993
21. Sztein MB, Steeg PS, Johnson HM, Oppenheim JJ: Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferon. J Clin Invest 73:556, 1984
22. de Waal Malefyt R, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
23. Ding L, Linsley PS, Huang L, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224, 1993
24. Willems F, Marchant A, Delville J, Gérard C, Delvaux A, Velu T, de Boer M, Goldman M: Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24:1007, 1994
25. Song S, Ling-Hu H, Roebuck KA, Rabbi MF, Donnelly RP, Finnegan A: Interleukin-10 inhibits interferon-γ-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood 89:4461, 1997
26. Hayes MP, Wang J, Norcross MA: Regulation of interleukin-12 expression in human monocytes: Selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646, 1995
27. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
28. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin 10. J Exp Med 174:1549, 1991
29. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182:1155, 1992
30. Gazzinelli RT, Oswald IP, James SL, Sher A: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 148:1792, 1992
31. Niiro H, Otsuka T, Abe M, Satoh H, Ogo T, Nakano T, Furukawa Y, Niho Y: Epstein-Barr virus BCRFI gene product (viral interleukin-10) inhibits superoxide anion production by human monocytes. Lymphokine Cytokine Res 11:209, 1992
32. Scheurich P, Köbrich G, Pfizenmaier K: Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. J Exp Med 170:947, 1989
33. Lien E, Liabakk N, Johnsen A, Nonstad U, Sundan A, Espevik T: Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 25:2714, 1995
34. Wahl LM, Katona IM, Wilder RL, Winter CC, Haroui B, Scher I, Wahl SM: Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B lymphocyte, T lymphocyte and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol 85:373, 1984
35. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
36. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724, 1984
37. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019, 1990
38. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
39. Santee SM, Owen-Schaub LB: Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 271:21151, 1996
40. Smith MF Jr, Eidlen D, Arend WP, Gutierrez-Hartmann A: LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 153:3584, 1994
41. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA: Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 152:4036, 1994
42. Aderka D, Engelmann H, Shemer-Avni Y, Hornik V, Galil A, Sarov B, Wallach D: Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 11:157, 1992
43. Chomarat P, Rissoan M-C, Banchereau J, Miossec P: Interferon-γ inhibits interleukin-10 production by monocytes. J Exp Med 177:523, 1993
44. Donnelly RP, Freeman SL, Hayes MP: Inhibition of IL-10 expression by interferon-γ up-regulates transcription of TNF-α in human monocytes. J Immunol 155:1420, 1995
45. Tannenbaum CS, Major JA, Hamilton TA: IFN-γ and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J Immunol 151:6833, 1993
46. Bemelmans MH, Gouma DJ, Buurman WA: LPS-induced sTNF-receptor release in vivo in a murine model: Investigation of the role of TNF, IL-1, LIF and IFN-γ. J Immunol 151:5554, 1993
47. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM: Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24:2699, 1994
48. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor-α production. J Exp Med 181:537, 1995
49. Fenton MJ, Buras JA, Donnelly RP: IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 149:1283, 1992
50. Vannier E, Miller LC, Dinarello CA: Coordinated anttinflammatory effects of IL-4: IL-4 suppresses IL-1 production but upregulates gene expression and synthesis of the IL-1 receptor antagonist. Proc Natl Acad Sci USA 89:4076, 1992
51. Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RMH, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 334:1697, 1996
52. Eason JD, Pascual M, Wee S, Farrell M, Phelan J, Boskovic S, Blosch C, Mohler KM, Cosimi AB: Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome. Transplantation 61:224, 1996
53. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA: A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492, 1995
54. Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, Affrime MB, Cutler DL: Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87:699, 1996
55. Winzen R, Wallach D, Engelmann H, Nophar Y, Brakebusch C, Kemper O, Resch K, Holtmann H: Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells. J Immunol 148:3454, 1992
56. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793, 1995
57. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 149:1666, 1992
58. Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner J, Glauser MP: IFN-γ involvement in the severity of gram-negative infections in mice. J Immunol 151:916, 1993
59. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547, 1993
60. Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205, 1993
61. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J: Mice that lack the interferon-γ receptor have profoundly altered responses to infection with BCG and subsequent challenge with lipopolysaccharide. J Exp Med 178:1435, 1993
62. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M, Ryffel B: Interferon-γ receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437, 1994
63. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, Grünig G, Rennick D: Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339, 1995